AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29

Authors: MONNET I BRIENZA S HUGRET F VOISIN S GASTIABURU J SALTIEL JC SOULIE P ARMAND JP CVITKOVIC E DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446

Authors: BEAUD C FUHRMAN C PERCHET H MONNET I CHOUAID C HOUSSET B
Citation: C. Beaud et al., THIAMINE-DEFICIENCY - A CAUSE OF HEART-FA ILURE NOT TO BE MISDIAGNOSED, Revue des maladies respiratoires, 15(3), 1998, pp. 303-304

Authors: CHOUAID C BASSINET L FUHRMAN C MONNET I HOUSSET B
Citation: C. Chouaid et al., ROUTINE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IS NOT COST-EFFECTIVE AND DOES NOT INCREASE PATIENT COMFORT IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - AN ANALYSIS USING A MARKOV MODEL, Journal of clinical oncology, 16(8), 1998, pp. 2700-2707

Authors: LAPLANCHE A MONNET I SANTOSMIRANDA JA BARDET E LEPECHOUX C TARAYRE M ARRIAGADA R
Citation: A. Laplanche et al., CONTROLLED CLINICAL-TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION, Lung cancer, 21(3), 1998, pp. 193-201

Authors: BUARD A VIVO C MONNET I BOUTIN C PILATTE Y JAURAND MC
Citation: A. Buard et al., HUMAN-MALIGNANT MESOTHELIOMA CELL-GROWTH - ACTIVATION OF JANUS KINASE-2 AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1-ALPHA FOR INHIBITION BY INTERFERON-GAMMA, Cancer research, 58(4), 1998, pp. 840-847

Authors: PHANBICH L BUARD A PETIT JF ZENG L TENU JP CHRETIEN P MONNET I BOUTIN C BIGNON J LEMAIRE G JAURAND MC
Citation: L. Phanbich et al., DIFFERENTIAL RESPONSIVENESS OF HUMAN AND RAT MESOTHELIOMA CELL-LINES TO RECOMBINANT INTERFERON-GAMMA, American journal of respiratory cell and molecular biology, 16(2), 1997, pp. 178-186

Authors: CIULEANU TE CHAHINE A TODOR N MONNET I AZLI N VOISIN S RIGGI M SALTIEL JC ARMAND JP RUFFIE P DECREMOUX H CVITKOVIC E
Citation: Te. Ciuleanu et al., NEOADJUVANT CISPLATIN-VINDESINE VINORELBINE BASED COMBINATION CHEMOTHERAPY (CT) FOR STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC)/, European journal of cancer, 33, 1997, pp. 1056-1056

Authors: TRANDAFIR L RUFFIE P BOREL C MONNET I SOULIE P ADAMS D CVITKOVIC E ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902

Authors: CHARIOT P DUBREUILLEMAIRE ML ZHOU JY LAMIA B DUME L LARCHER B MONNET I LEVY Y ASTIER A GHERARDI R
Citation: P. Chariot et al., MUSCLE INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS IS ASSOCIATED WITH MARKED SELENIUM DEFICIENCY, Muscle & nerve, 20(3), 1997, pp. 386-389

Authors: SOULIE P RUFFIE P TRANDAFIR L MONNET I TARDIVON A TERRIER P CVITKOVIC E LECHEVALIER T ARMAND JP
Citation: P. Soulie et al., COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A, Journal of clinical oncology, 14(3), 1996, pp. 878-885

Authors: ARRIAGADA R LECHEVALIER T BORIE F RIVIERE A CHOMY P MONNET I TARDIVON A VIADER F TARAYRE M BENHAMOU S
Citation: R. Arriagada et al., PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION, Journal of the National Cancer Institute, 87(3), 1995, pp. 183-190

Authors: ARRIAGADA R MONNET I RIVIERE A SANTOSMIRANDA JA BARDET E LAPLANCHE A
Citation: R. Arriagada et al., PROPHYLACTIC CRANIAL IRRADIATION (PCI) FOR PATIENTS (PTS) WITH SMALL-CELL LUNG-CANCER (SCLC) IN COMPLETE REMISSION (CR), European journal of cancer, 31A, 1995, pp. 83-83

Authors: FLEURYFEITH J KHEUANG L ZENG L BIGNON J BOUTIN C MONNET I JAURAND MC
Citation: J. Fleuryfeith et al., HUMAN-MALIGNANT MESOTHELIAL CELLS - VARIABILITY OF ULTRASTRUCTURAL FEATURES IN ESTABLISHED AND NUDE-MICE TRANSPLANTED CELL-LINES, Journal of pathology, 177(2), 1995, pp. 209-215

Authors: AISNER J BOUTIN C BUTCHART EG CHAHINIAN P FABER LP HEELAN R MATTSON K PASS HI PATZ EF ROBINSON B RUSCH VW TAMMILEHTO L VOGELZANG NJ AISNER S ANTMAN KH BELANI CP BIGNON J BRODIN O FEINS R GINSBERG R HAMMAR S HERNDON J HILLARDEL G ILSON D KELLER S KELSEN D KRASNA M MAASILTA P MONNET I ROGGLI VL RUFFIE P SALMINEN U SALTZ L STRAUSS G VIALLAT JR VONBULTZINGSLOWEN F
Citation: J. Aisner et al., A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA, Chest, 108(4), 1995, pp. 1122-1128

Authors: PIGNON JP TARAYRE M AUQUIER A ARRIAGADA R LECHEVALIER T RUFFIE P RIVIERE A MONNET I CHOMY P TUCHAIS C
Citation: Jp. Pignon et al., TRIANGULAR TEST AND RANDOMIZED TRIALS - PRACTICAL PROBLEMS IN A SMALLLUNG-CANCER TRIAL, Statistics in medicine, 13(13-14), 1994, pp. 1415-1421

Authors: ZENG L FLEURYFEITH J MONNET I BOUTIN C BIGNON J JAURAND MC
Citation: L. Zeng et al., IMMUNOCYTOCHEMICAL CHARACTERIZATION OF CELL-LINES FROM HUMAN-MALIGNANT MESOTHELIOMA - CHARACTERIZATION OF HUMAN MESOTHELIOMA CELL-LINES BY IMMUNOCYTOCHEMISTRY WITH A PANEL OF MONOCLONAL-ANTIBODIES, Human pathology, 25(3), 1994, pp. 227-234

Authors: MONTI G JAURAND MC MONNET I CHRETIEN P SAINTETIENNE L ZENG L PORTIER A DEVILLIER P GALANAUD P BIGNON J EMILIE D
Citation: G. Monti et al., INTRAPLEURAL PRODUCTION OF INTERLEUKIN-6 DURING MESOTHELIOMA AND ITS MODULATION BY GAMMA-INTERFERON TREATMENT, Cancer research, 54(16), 1994, pp. 4419-4423

Authors: BOUTIN C NUSSBAUM E MONNET I BIGNON J VANDERSCHUEREN R GUERIN JC MENARD O MIGNOT P DABOUIS G DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467

Authors: BOUTIN C NUSSBAUM E MONNET I BIGNON J VANDERSCHUEREN R GUERIN JC MENARD O MIGNOT P DABOUIS G DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467

Authors: CHARIOT P MONNET I MOUCHET M ROHR M LEFAUCHEUR JP DUBREUILLEMAIRE ML CHOUSTERMAN M GHERARDI R
Citation: P. Chariot et al., DETERMINATION OF THE BLOOD LACTATE-PYRUVATE RATIO AS A NONINVASIVE TEST FOR THE DIAGNOSIS OF ZIDOVUDINE MYOPATHY, Arthritis and rheumatism, 37(4), 1994, pp. 583-586

Authors: MACCHIARINI P CHAPELIER AR MONNET I VANNETZEL JM REBISCHUNG JL CERRINA J PARQUIN F LADURIE FL LENOT B DARTEVELLE PG
Citation: P. Macchiarini et al., EXTENDED OPERATIONS AFTER INDUCTION THERAPY FOR STAGE IIIB (T4) NONSMALL CELL LUNG-CANCER, The Annals of thoracic surgery, 57(4), 1994, pp. 966-973

Authors: RIGGI M CVITKOVIC E DECREMOUX H RUFFIE P MONNET I VOISIN S VILLALOBOS W AZLI N SALTIEL JC
Citation: M. Riggi et al., CISPLATIN AND CONTINUOUS-INFUSION VINDESINE AND 5-FLUOROURACIL IN NON-SMALL-CELL LUNG-CANCER (NSCLC) (ATTIT-002), European journal of cancer, 29A(13), 1993, pp. 1914-1915

Authors: CHARIOT P MONNET I GHERARDI R
Citation: P. Chariot et al., CYTOCHROME-C-OXIDASE REACTION IMPROVES HISTOPATHOLOGICAL ASSESSMENT OF ZIDOVUDINE MYOPATHY, Annals of neurology, 34(4), 1993, pp. 561-565
Risultati: 1-25 | 26-29